Logo-ps
Submitted: 15 Jan 2025
Revision: 03 Mar 2025
Accepted: 10 Mar 2025
ePublished: 19 Apr 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Pharm Sci. Inpress.
doi: 10.34172/PS.025.42140
  Abstract View: 13

Research Article

Development and Characterization of Liposomal Phytoformulation of Piper longum L. for Melanoma Therapy

Himani . 1 ORCID logo, Debadatta Mohapatra 1 ORCID logo, Singh Shreya 1,2 ORCID logo, Satyajeet Biswal 3 ORCID logo, Gaurav Gopal Naik 1 ORCID logo, Soki Daeme Malang 1 ORCID logo, Pooja Kathait 1 ORCID logo, Pradeep Kumar Patel 1 ORCID logo, Shambhavi . 1 ORCID logo, Prakash Ch. Senapati 4, Pratap Chandra Acharya 3 ORCID logo, Alakh Niranjan Sahu 1* ORCID logo

1 Phytomedicine Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi-221005, India
2 Department of Pharmacology, SBS College of Pharmacy, Malwan, Fatehpur-212664, Indi
3 Drug Metabolomics Laboratory, Department of Pharmacy, Tripura University (A Central University), Suryamaninagar-799022, Tripura, India
4 Department of Pharmaceutics, IMT Pharmacy College, Gopalpur, Puri-752004, Odisha, Indi
*Corresponding Author: Email: ansahu.phe@itbhu.ac.in

Abstract

Background: Melanoma is a highly destructive and lethal form of skin cancer. With the contemplation of the concept of plant-based chemotherapeutic and nanomedicine approach, this study aims to develop a liposome of standardized Piper longum L. fruit ethanolic extract (PLFEE), with the evaluation of its pharmaceutical properties and cytotoxic activities against melanoma cell line. To our knowledge, no authentic reports are available for the standardized PLFEE-loaded liposome for melanoma therapy.

Methods: The chemical marker-based standardization of PLFEE was performed by validated High-performance liquid chromatography (HPLC) to maintain the dosage uniformity and uniform therapeutic outcome. Thin-film hydration was utilized for the formulation of liposomes. The developed liposome was characterized for its pharmaceutical possessions and therapeutic activity against melanoma cell lines.

Results: The prepared liposome was found to be homogeneous, amorphous, transparent, light yellowish, demonstrated nano vesicular size (Zavg=104.858±0.262 nm), low polydispersity index (PDI=0.271±0.015), high zeta potential (ζ= -21.8±0.07 mV), spherical morphology, excellent % entrapment efficiency (EE=75.920±3.096%), refractive index (RI= 1.335±0.0001), sustained drug release, excellent drug-excipient compatibility, and stability. The liposome showed selective cytotoxicity to B16F10 melanoma cells without affecting healthy HEK293 kidney cells. The PLFEE-loaded liposome showed significantly enhanced cytotoxicity (IC50=59.71 ± 2.364 µg/mL) compared to PLFEE (88.48 ± 3.243 μg/mL).

Conclusion: Cancer cells use various pathways for their uncontrolled, abnormal proliferation, angiogenesis, invasion, and metastasis. It is, therefore, logical to utilize a multicomponent-based standardized herbal extract that may act through multiple molecular pathways. The liposomal formulation containing multiconstituent-based standardized PLFEE may be a potential alternative chemotherapeutic for melanoma therapy. However, comprehensive in-vivo works are essential to reveal its therapeutic potential.


First Name
Last Name
Email Address
Comments
Security code


Abstract View: 12

Your browser does not support the canvas element.


PDF Download: 0

Your browser does not support the canvas element.